These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19997956)

  • 1. The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands.
    Keogh-Brown MR; Smith RD; Edmunds JW; Beutels P
    Eur J Health Econ; 2010 Dec; 11(6):543-54. PubMed ID: 19997956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the economic impact of pandemic influenza: An application of the computable general equilibrium model to the U.K.
    Smith RD; Keogh-Brown MR; Barnett T
    Soc Sci Med; 2011 Jul; 73(2):235-44. PubMed ID: 21708419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment.
    Smith RD; Keogh-Brown MR; Barnett T; Tait J
    BMJ; 2009 Nov; 339():b4571. PubMed ID: 19926697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Economic Consequences of an Influenza Outbreak in the United States.
    Prager F; Wei D; Rose A
    Risk Anal; 2017 Jan; 37(1):4-19. PubMed ID: 27214756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroeconomic impact of a mild influenza pandemic and associated policies in Thailand, South Africa and Uganda: a computable general equilibrium analysis.
    Smith RD; Keogh-Brown MR
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1400-8. PubMed ID: 23822177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroeconomic impact of pandemic influenza and associated policies in Thailand, South Africa and Uganda.
    Smith RD; Keogh-Brown MR
    Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):64-71. PubMed ID: 24034487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
    Nuño M; Chowell G; Gumel AB
    J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible macroeconomic impact on the UK of an influenza pandemic.
    Keogh-Brown MR; Wren-Lewis S; Edmunds WJ; Beutels P; Smith RD
    Health Econ; 2010 Nov; 19(11):1345-60. PubMed ID: 19816886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.
    Sander B; Nizam A; Garrison LP; Postma MJ; Halloran ME; Longini IM
    Value Health; 2009; 12(2):226-33. PubMed ID: 18671770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the costs of school closure for mitigating an influenza pandemic.
    Sadique MZ; Adams EJ; Edmunds WJ
    BMC Public Health; 2008 Apr; 8():135. PubMed ID: 18435855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulating school closure policies for cost effective pandemic decision making.
    Araz OM; Damien P; Paltiel DA; Burke S; van de Geijn B; Galvani A; Meyers LA
    BMC Public Health; 2012 Jun; 12():449. PubMed ID: 22713694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.
    Postma MJ; Milne G; Nelson EA; Pyenson B; Basili M; Coker R; Oxford J; Garrison LP;
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1431-9. PubMed ID: 21133667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. School closure policies at municipality level for mitigating influenza spread: a model-based evaluation.
    Ciavarella C; Fumanelli L; Merler S; Cattuto C; Ajelli M
    BMC Infect Dis; 2016 Oct; 16(1):576. PubMed ID: 27756233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of preemptive school closures to mitigate pandemic influenza outbreaks of differing severity in the United States.
    Dauelsberg LR; Maskery B; Joo H; Germann TC; Del Valle SY; Uzicanin A
    BMC Public Health; 2024 Jan; 24(1):200. PubMed ID: 38233845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health. Be prepared: what work in fight against flu.
    Beresniak A
    Health Serv J; 2014 May; 124(6399):19-21. PubMed ID: 25029766
    [No Abstract]   [Full Text] [Related]  

  • 16. Modeling the economic impact of pandemic influenza: a case study in Turkey.
    Yoldascan E; Kurtaran B; Koyuncu M; Koyuncu E
    J Med Syst; 2010 Apr; 34(2):139-45. PubMed ID: 20433052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitigation of pandemic influenza: review of cost-effectiveness studies.
    Lugnér AK; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly monitoring of influenza impact in Belgium (1993-1995).
    Snacken R
    Pharmacoeconomics; 1996; 9 Suppl 3():34-7; discussion 50-3. PubMed ID: 10160484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies.
    Newall AT; Wood JG; Oudin N; MacIntyre CR
    Emerg Infect Dis; 2010 Feb; 16(2):224-30. PubMed ID: 20113551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.
    Khazeni N; Hutton DW; Garber AM; Owens DK
    Ann Intern Med; 2009 Dec; 151(12):840-53. PubMed ID: 20008760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.